Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
3
33%
Ph phase_4
2
22%
Ph not_applicable
2
22%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 33 (33.3%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

completed444%
not_yet_recruiting111%
terminated111%
unknown333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9